| SC 13G/A | 2022-02-11 | CHI Advisors LLC | PLIANT THERAPEUTICS, INC. | 2,569,479 | 7.1% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | PLIANT THERAPEUTICS, INC. | 5,405,849 | 15.0% | EDGAR |
| SC 13G | 2021-03-02 | CHI Advisors LLC | PLIANT THERAPEUTICS, INC. | 2,354,799 | 6.6% | EDGAR |
| SC 13G/A | 2021-02-16 | Redmile Group, LLC | PLIANT THERAPEUTICS, INC. | 3,388,376 | 9.6% | EDGAR |
| SC 13G | 2021-02-16 | Third Rock Ventures III, L.P. | PLIANT THERAPEUTICS, INC. | 5,839,160 | 16.5% | EDGAR |
| SC 13G | 2021-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | PLIANT THERAPEUTICS, INC. | 2,838,125 | 8.0% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | PLIANT THERAPEUTICS, INC. | 5,322,156 | 15.0% | EDGAR |
| SC 13G | 2020-07-10 | FMR LLC | PLIANT THERAPEUTICS, INC. | 5,332,701 | 15.0% | EDGAR |
| SC 13G | 2020-06-15 | Novartis Institutes for BioMedical Research, Inc. | PLIANT THERAPEUTICS, INC. | 2,153,526 | 6.1% | EDGAR |
| SC 13G | 2020-06-09 | Redmile Group, LLC | PLIANT THERAPEUTICS, INC. | 3,410,657 | 9.6% | EDGAR |